Erythropoietin in Infants With Hypoxic Ischemic Encephalopathy (HIE)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
In this prospective trial the investigators plan to study the efficacy of erythropoietin as a
therapeutic agent in neonates who suffer from brain injury following perinatal asphyxia.